Jafar Amani

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 19

Top Venues

Iranian journal of pharmaceutical research : IJPR

Clinical and experimental vaccine research

Journal of cellular biochemistry

Molecular biology reports

Baqiyatallah University of Medical Sciences

Baqiyatallah University of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Baqiyatallah University of Medical Sciences

Iran

Associate Professor :: Applied Microbiology Research Center

Education History

Baqiyatallah University of Medical Sciences

Iran

PHD :: Applied Microbiology Research Center

Publications

Nafiseh Shafiei, Hamideh Mahmoodzadeh Hosseini, Jafar Amani, Seyed Ali Mirhosseini, Hanieh Jafary
Screening and identification of DNA nucleic acid aptamers against F1 protein of Yersinia pestis using SELEX method. Molecular biology reports 51 (1) (2024)
Somayeh Heidarian, Laya Takbiri Osgoei, Shohreh Zare Karizi, Jafar Amani, Sedigheh Arbabian
Signal-On Fluorescence Biosensor for Detection of miRNA-21 Based on ROX labeled Specific Stem-Loop Probe. Iranian journal of pharmaceutical research : IJPR 23 (1) (2024)
Ali Saffaei, Jafar Amani, Jafar Salimian, Gholamhossein Alishiri, Hassan Abolghasemi
Comments on "Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice". Iranian journal of immunology : IJI 21 (3) (2024)
Somayeh Heidarian, Laya Takbiri Osgoei, Shohreh Zare Karizi, Jafar Amani, Sedigheh Arbabian
Signal-On Fluorescence Biosensor for Detection of miRNA-21 Based on ROX labeled Specific Stem-Loop Probe. Iranian journal of pharmaceutical research : IJPR 23 (1) (2024)
Nafiseh Shafiei, Hamideh Mahmoodzadeh Hosseini, Jafar Amani, Seyed Ali Mirhosseini, Hanieh Jafary
Screening and identification of DNA nucleic acid aptamers against F1 protein of Yersinia pestis using SELEX method. Molecular biology reports 51 (1) (2024)
Razieh Rezaei Adriani, Seyed Latif Mousavi Gargari, Hamid Bakherad, Jafar Amani
Anti-EGFR bioengineered bacterial outer membrane vesicles as targeted immunotherapy candidate in triple-negative breast tumor murine model. Scientific reports 13 (1) (2023)
Sahar Karimi, Shahram Nazarian, Fattah Sotoodehnejadnematalahi, Roohollah Dorostkar, Jafar Amani
Designing and Expression of Recombinant Chimeric Spike Protein from SARS-CoV-2 in Escherichia coli and Its Immunogenicity Assessment. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Hafizeh Haghighatafshar, Bahram Golestani Eimani, Elham Moazamian, Jafar Amani
The anticancer effect of recombinant LukS-PV protein and silver nanoparticles loaded with this protein. AMB Express 13 (1) (2023)
Nafiseh Shafiei, Hamideh Mahmoodzadeh Hosseini, Jafar Amani, Seyed Ali Mirhosseini, Hanieh Jafary
Screening and Identification of DNA Nanostructure Aptamer Using the SELEX Method for ‎Detection of Epsilon Toxin. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Sahar Karimi, Shahram Nazarian, Fattah Sotoodehnejadnematalahi, Roohollah Dorostkar, Jafar Amani
Designing and Expression of Recombinant Chimeric Spike Protein from SARS-CoV-2 in Escherichia coli and Its Immunogenicity Assessment. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Nafiseh Shafiei, Hamideh Mahmoodzadeh Hosseini, Jafar Amani, Seyed Ali Mirhosseini, Hanieh Jafary
Screening and Identification of DNA Nanostructure Aptamer Using the SELEX Method for ‎Detection of Epsilon Toxin. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Jafar Salimian, Ali Ahmadi, Jafar Amani, Gholamreza Olad, Raheleh Halabian, Ali Saffaei, Masoud Arabfard, Mojtaba Nasiri, Shahram Nazarian, Hassan Abolghasemi, Gholamhossein Alishiri
Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial. Journal of medical virology (2022)
Rasool Mirzaei Seveiri, Masoud Hamidi, Cédric Delattre, Hamid Sedighian, Guillaume Pierre, Babak Rahmani, Sina Darzi, Clément Brasselet, Fatemeh Karimitabar, Ali Razaghpoor, Jafar Amani
Characterization and Prospective Applications of the Exopolysaccharides Produced by Rhodosporidium babjevae. Advanced pharmaceutical bulletin 10 (2) (2020)
Seyed Ali Mirhosseini, Mohammad Sarfi, Sadra Samavarchi Tehrani, Mohammad Mirazakhani, Mahmood Maniati, Jafar Amani
Modulation of cancer cell signaling by long noncoding RNAs. Journal of cellular biochemistry 120 (8) (2019)
Mahmoud Gharbavi, Jafar Amani, Hamidreza Kheiri-Manjili, Hossein Danafar, Ali Sharafi
Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier. Advances in pharmacological sciences 2018 (2018)
Sadra Samavarchi Tehrani, Hamideh Mahmoodzadeh Hosseini, Tooba Yousefi, Maryam Abolghasemi, Durdi Qujeq, Mahmood Maniati, Jafar Amani
The crosstalk between trace elements with DNA damage response, repair, and oxidative stress in cancer. Journal of cellular biochemistry (2018)
Zahra Sadat Hosseini, Jafar Amani, Fahimeh Baghbani Arani, Shahram Nazarian, Mohammad Javad Motamedi, Fatemeh Shafighian
Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice. Clinical and experimental vaccine research 7 (1) (2018)
Ahmad Karkhah, Jafar Amani
A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approach. Clinical and experimental vaccine research 5 (1) (2016)
Somayeh Delfani, Abbas Ali Imani Fooladi, Ashraf Mohabati Mobarez, Mohammad Emaneini, Jafar Amani, Hamid Sedighian
In silico analysis for identifying potential vaccine candidates against Staphylococcus aureus. Clinical and experimental vaccine research 4 (1) (2015)

Jafar Amani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jafar Amani